These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1926 related items for PubMed ID: 24440207

  • 1. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England.
    Le Menach A, Boxall N, Amirthalingam G, Maddock L, Balasegaram S, Mindlin M.
    Vaccine; 2014 Feb 26; 32(10):1147-52. PubMed ID: 24440207
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the measles, mumps and rubella vaccination catch-up campaign in England in 2013.
    Simone B, Balasegaram S, Gobin M, Anderson C, Charlett A, Coole L, Maguire H, Nichols T, Rawlings C, Ramsay M, Oliver I.
    Vaccine; 2014 Aug 06; 32(36):4681-8. PubMed ID: 24996125
    [Abstract] [Full Text] [Related]

  • 3. Why do parents hesitate to vaccinate their children against measles, mumps and rubella?
    Alfredsson R, Svensson E, Trollfors B, Borres MP.
    Acta Paediatr; 2004 Sep 06; 93(9):1232-7. PubMed ID: 15384890
    [Abstract] [Full Text] [Related]

  • 4. The two-dose measles, mumps, and rubella (MMR) immunisation schedule: factors affecting maternal intention to vaccinate.
    Pareek M, Pattison HM.
    Br J Gen Pract; 2000 Dec 06; 50(461):969-71. PubMed ID: 11224968
    [Abstract] [Full Text] [Related]

  • 5. The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme.
    Miller E, Waight P, Gay N, Ramsay M, Vurdien J, Morgan-Capner P, Hesketh L, Brown D, Tookey P, Peckham C.
    Commun Dis Rep CDR Rev; 1997 Feb 07; 7(2):R26-32. PubMed ID: 9046126
    [Abstract] [Full Text] [Related]

  • 6. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
    Bae GR, Choe YJ, Go UY, Kim YI, Lee JK.
    Vaccine; 2013 May 31; 31(24):2661-6. PubMed ID: 23602654
    [Abstract] [Full Text] [Related]

  • 7. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P, Amstad H, Grize L, Gassner M, Takken-Sahli K, Bourquin C, Braun-Fahrländer C.
    Praxis (Bern 1994); 1999 Jun 10; 88(24):1069-77. PubMed ID: 10420798
    [Abstract] [Full Text] [Related]

  • 8. Impact of a third dose of measles-mumps-rubella vaccine on a mumps outbreak.
    Ogbuanu IU, Kutty PK, Hudson JM, Blog D, Abedi GR, Goodell S, Lawler J, McLean HQ, Pollock L, Rausch-Phung E, Schulte C, Valure B, Armstrong GL, Gallagher K.
    Pediatrics; 2012 Dec 10; 130(6):e1567-74. PubMed ID: 23129075
    [Abstract] [Full Text] [Related]

  • 9. Characterisation of measles after the introduction of the combined measles-mumps-rubella (MMR) vaccine in 2004 with focus on the laboratory data, 2016 to 2019 outbreak, Romania.
    Lazar M, Stănescu A, Penedos AR, Pistol A.
    Euro Surveill; 2019 Jul 10; 24(29):. PubMed ID: 31339098
    [Abstract] [Full Text] [Related]

  • 10. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).
    McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS, Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 2013 Jun 14; 62(RR-04):1-34. PubMed ID: 23760231
    [Abstract] [Full Text] [Related]

  • 11. The potential for measles transmission in England.
    Choi YH, Gay N, Fraser G, Ramsay M.
    BMC Public Health; 2008 Sep 26; 8():338. PubMed ID: 18822142
    [Abstract] [Full Text] [Related]

  • 12. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K, Nicoara C, Germann D, Matter L.
    Schweiz Med Wochenschr; 1998 Apr 25; 128(17):649-57. PubMed ID: 9622837
    [Abstract] [Full Text] [Related]

  • 13. MMR vaccination and disease elimination: the Finnish experience.
    Davidkin I, Kontio M, Paunio M, Peltola H.
    Expert Rev Vaccines; 2010 Sep 25; 9(9):1045-53. PubMed ID: 20822347
    [Abstract] [Full Text] [Related]

  • 14. Opportunistic MMR vaccination for unimmunized children at the time of routine teenage booster vaccination in secondary schools: implications for policy.
    Paranthaman K, Bunce A.
    Epidemiol Infect; 2012 Sep 25; 140(9):1612-6. PubMed ID: 22117122
    [Abstract] [Full Text] [Related]

  • 15. The contribution of single antigen measles, mumps and rubella vaccines to immunity to these infections in England and Wales.
    Sonnenberg P, Crowcroft NS, White JM, Ramsay ME.
    Arch Dis Child; 2007 Sep 25; 92(9):786-9. PubMed ID: 17412744
    [Abstract] [Full Text] [Related]

  • 16. Clinical Practices for Measles-Mumps-Rubella Vaccination Among US Pediatric International Travelers.
    Hyle EP, Rao SR, Bangs AC, Gastañaduy P, Fiebelkorn AP, Hagmann SHF, Walker AT, Walensky RP, Ryan ET, LaRocque RC.
    JAMA Pediatr; 2020 Feb 01; 174(2):e194515. PubMed ID: 31816033
    [Abstract] [Full Text] [Related]

  • 17. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England.
    Cohen C, White JM, Savage EJ, Glynn JR, Choi Y, Andrews N, Brown D, Ramsay ME.
    Emerg Infect Dis; 2007 Jan 01; 13(1):12-7. PubMed ID: 17370510
    [Abstract] [Full Text] [Related]

  • 18. Specialist vaccination advice and pockets of resistance to MMR vaccination: lessons from an outbreak of measles.
    Morgan OW, Meltzer M, Muir D, Hogan H, Seng C, Hill J, Beckford J.
    Commun Dis Public Health; 2003 Dec 01; 6(4):330-3. PubMed ID: 15067861
    [Abstract] [Full Text] [Related]

  • 19. Serosurvey of measles, mumps and rubella antibodies in Saudi children.
    Al-Mazrou YY, Khalil MK, Tischer A, Al-Jeffri MH, Al-Ghamdi YS, Bakhsh MM, Mishkas AA, Elgizouli SA.
    Saudi Med J; 2005 Oct 01; 26(10):1551-4. PubMed ID: 16228054
    [Abstract] [Full Text] [Related]

  • 20. Difficulties in eliminating measles and controlling rubella and mumps: a cross-sectional study of a first measles and rubella vaccination and a second measles, mumps, and rubella vaccination.
    Wang Z, Yan R, He H, Li Q, Chen G, Yang S, Chen E.
    PLoS One; 2014 Oct 01; 9(2):e89361. PubMed ID: 24586717
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 97.